Segment Information (Tables)
|
9 Months Ended |
Jun. 28, 2026 |
|---|
| Segment Reporting [Abstract] |
|
| Revenues and EBT for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | | QCT: | | | | | | | | | Revenues | $ | 8,504 | | | $ | 8,993 | | | $ | 28,193 | | | $ | 28,546 | | | Cost of revenues | 4,452 | | | 4,497 | | | 14,598 | | | 14,395 | | | Operating expenses (R&D and SG&A) | 1,860 | | | 1,825 | | | 5,636 | | | 5,377 | | | EBT | $ | 2,192 | | | $ | 2,671 | | | $ | 7,959 | | | $ | 8,774 | | | QTL: | | | | | | | | | Revenues | $ | 1,278 | | | $ | 1,318 | | | $ | 4,252 | | | $ | 4,172 | | Costs and expenses (1) | 397 | | | 376 | | | 1,147 | | | 1,144 | | | EBT | $ | 881 | | | $ | 942 | | | $ | 3,105 | | | $ | 3,028 | | | QSI: | | | | | | | | | Revenues | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | Operating expenses | 3 | | | 3 | | | 8 | | | 9 | | | Investment and other income, net | 771 | | | 152 | | | 925 | | | 188 | | | EBT | $ | 768 | | | $ | 149 | | | $ | 917 | | | $ | 179 | |
(1) Substantially all of QTL’s costs and expenses are comprised of operating expenses.
|
| Reconciling items for reportable segments - revenues |
Consolidated revenues and EBT include the following reconciling items (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | | Revenues | | | | | | | | | Reportable segments | $ | 9,782 | | | $ | 10,311 | | | $ | 32,445 | | | $ | 32,718 | | | Nonreportable segments | 165 | | | 54 | | | 353 | | | 152 | | Unallocated revenues | — | | | — | | | — | | | 143 | | | $ | 9,947 | | | $ | 10,365 | | | $ | 32,798 | | | $ | 33,013 | | | EBT | | | | | | | | Reportable segments | $ | 3,841 | | | $ | 3,762 | | | $ | 11,981 | | | $ | 11,981 | | | Nonreportable segments | (214) | | | (10) | | | (419) | | | (15) | | Unallocated revenues | — | | | — | | | — | | | 143 | | | Unallocated cost of revenues | (97) | | | (65) | | | (272) | | | (185) | | | Unallocated R&D expenses | (755) | | | (595) | | | (2,069) | | | (1,752) | | | Unallocated SG&A expenses | (323) | | | (182) | | | (896) | | | (554) | | Unallocated other expenses | (68) | | | — | | | (97) | | | — | | | Unallocated interest expense | (178) | | | (168) | | | (519) | | | (493) | | | Unallocated investment and other income, net | 256 | | | 210 | | | 532 | | | 567 | | | $ | 2,462 | | | $ | 2,952 | | | $ | 8,241 | | | $ | 9,692 | |
|
| Reconciling items for reportable segments - EBT |
Consolidated revenues and EBT include the following reconciling items (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | | Revenues | | | | | | | | | Reportable segments | $ | 9,782 | | | $ | 10,311 | | | $ | 32,445 | | | $ | 32,718 | | | Nonreportable segments | 165 | | | 54 | | | 353 | | | 152 | | Unallocated revenues | — | | | — | | | — | | | 143 | | | $ | 9,947 | | | $ | 10,365 | | | $ | 32,798 | | | $ | 33,013 | | | EBT | | | | | | | | Reportable segments | $ | 3,841 | | | $ | 3,762 | | | $ | 11,981 | | | $ | 11,981 | | | Nonreportable segments | (214) | | | (10) | | | (419) | | | (15) | | Unallocated revenues | — | | | — | | | — | | | 143 | | | Unallocated cost of revenues | (97) | | | (65) | | | (272) | | | (185) | | | Unallocated R&D expenses | (755) | | | (595) | | | (2,069) | | | (1,752) | | | Unallocated SG&A expenses | (323) | | | (182) | | | (896) | | | (554) | | Unallocated other expenses | (68) | | | — | | | (97) | | | — | | | Unallocated interest expense | (178) | | | (168) | | | (519) | | | (493) | | | Unallocated investment and other income, net | 256 | | | 210 | | | 532 | | | 567 | | | $ | 2,462 | | | $ | 2,952 | | | $ | 8,241 | | | $ | 9,692 | |
|